ArticleAging2019

Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment.

Chen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.